Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CU-CPD107 is a selective agonist of toll-like receptor 8 (TLR8) and also shows activation activity against ssRNA ligands. CU-CPD107 acts as an inhibitor of TLR8 signaling in the presence of R848 (IC50=13.7 μM). CU-CPD107 exhibited coagonist activity in the presence of ssRNA, while CU-CPD107 alone could not affect TLR8 signal transduction.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 64.00 | |
5 mg | In stock | $ 137.00 | |
10 mg | In stock | $ 217.00 | |
25 mg | In stock | $ 398.00 | |
50 mg | In stock | $ 565.00 | |
100 mg | In stock | $ 793.00 |
Description | CU-CPD107 is a selective agonist of toll-like receptor 8 (TLR8) and also shows activation activity against ssRNA ligands. CU-CPD107 acts as an inhibitor of TLR8 signaling in the presence of R848 (IC50=13.7 μM). CU-CPD107 exhibited coagonist activity in the presence of ssRNA, while CU-CPD107 alone could not affect TLR8 signal transduction. |
Targets&IC50 | TLR8 (HEK-Blue hTLR8 cells):13.7 μM |
In vitro | CU-CPD107 behaved an agonist in the presence of ssRNA in HEK-Blue hTLR8 cells, resulting in a fivefold activation at 100 μΜ by SEAP assay relative to the control. Crucially, CU-CPD107 displayed no agonistic potential in the absence of ssRNA[1]. |
Synonyms | CU-CPD107 |
Molecular Weight | 400.25 |
Formula | C16H21IN2O2 |
CAS No. | 2573912-32-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 1.8 mg/mL (4.5 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CU-CPD107 2573912-32-8 Immunology/Inflammation TLR CU-CPD-107 CUCPD107 CU CPD107 CU-CPD 107 inhibitor inhibit